Authorisation of veterinary medicinal products containing (potential) persistent, bioaccumulative and toxic (PBT) or very persistent and very bioaccumulative (vPvB) substances

Current version

PDF icon<b>Adopted reflection paper</b>

Reference numberEMA/CVMP/448211/2015
Published23/05/2017
KeywordsPBT criteria, PBT emmission, PBT risk management, veterinary medicinal product (VMP), aquatic, terrestrial
DescriptionThis document reflects the need for a strategic approach to the assessment of the risks posed by veterinary medicinal products containing potential persistent, bioaccumulative substances.


Document history

First version

Current version

Adopted reflection paper

Overview of comments

PDF iconDraft reflection paper

In operation: 11/05/2017 - present

Published: 23/05/2017

Published: 26/02/2016


Related content


How useful was this page?

Add your rating